Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (391-400 of 1,113) with videos related to

Pageof 112
Sort By:
Journal of the American College of Cardiology|November 9, 2019
Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic RangeGregory Y H Lip, Deepak L Bhatt, Stefan H Hohnloser, et al.
Circulation|July 16, 2008
Relation between body mass index, waist circumference, and death after acute myocardial infarctionMarianne Zeller, Philippe Gabriel Steg, Jack Ravisy, et al.
Circulation|November 21, 2007
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?Frederick A Spencer, Mauro Moscucci, Christopher B Granger, et al.
Atherosclerosis|December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryPatrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.
Clinical Cardiology|September 3, 2016
Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH RegistryJérémie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Journal of the American College of Cardiology|September 5, 2006
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trialGilles Montalescot, Georges Sideris, Catherine Meuleman, et al.
Circulation|January 28, 2004
Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)Philippe Gabriel Steg, Omar H Dabbous, Laurent J Feldman, et al.
Atherosclerosis|February 11, 2012
Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomesMaria Teresa B Abola, Deepak L Bhatt, Sue Duval, et al.
Plos One|July 23, 2014
Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patientsPaul R Kalra, Xavier García-Moll, José Zamorano, et al.
European Heart Journal. Acute Cardiovascular Care|March 1, 2015
Impact of participation in randomized trials of reperfusion therapy on the time to reperfusion and hospital mortality in ST-segment elevation myocardial infarction: A single-centre cohort studyJean-Michel Juliard, Jean-Louis Golmard, Laurent J Feldman, et al.
Pageof 112

Showing results (391-400 of 1,113) with videos related to

Sort By:
Pageof 112
Journal of the American College of Cardiology|November 9, 2019
Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic RangeGregory Y H Lip, Deepak L Bhatt, Stefan H Hohnloser, et al.
Circulation|July 16, 2008
Relation between body mass index, waist circumference, and death after acute myocardial infarctionMarianne Zeller, Philippe Gabriel Steg, Jack Ravisy, et al.
Circulation|November 21, 2007
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?Frederick A Spencer, Mauro Moscucci, Christopher B Granger, et al.
Atherosclerosis|December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryPatrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.
Clinical Cardiology|September 3, 2016
Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH RegistryJérémie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Journal of the American College of Cardiology|September 5, 2006
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trialGilles Montalescot, Georges Sideris, Catherine Meuleman, et al.
Circulation|January 28, 2004
Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)Philippe Gabriel Steg, Omar H Dabbous, Laurent J Feldman, et al.
Atherosclerosis|February 11, 2012
Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomesMaria Teresa B Abola, Deepak L Bhatt, Sue Duval, et al.
Plos One|July 23, 2014
Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patientsPaul R Kalra, Xavier García-Moll, José Zamorano, et al.
European Heart Journal. Acute Cardiovascular Care|March 1, 2015
Impact of participation in randomized trials of reperfusion therapy on the time to reperfusion and hospital mortality in ST-segment elevation myocardial infarction: A single-centre cohort studyJean-Michel Juliard, Jean-Louis Golmard, Laurent J Feldman, et al.
Pageof 112